Iodide

Iodide

SCHEMBL7766682

N#Cc1cccc(C(=O)C[n+]2ccccc2)n1.[I-]

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PABPC1 P11940 1/20 0.43
AHR P35869 1/20 0.43
ALDH1A1 P00352 1/20 0.42
KDM4E B2RXH2 2/20 0.40
CES1 P23141 1/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
MAPT P10636 2/20 0.36
POLB P06746 2/20 0.36
RAB9A P51151 1/20 0.34
DAGLA Q9Y4D2 1/20 0.34
HSP90AA1 P07900 2/20 0.33
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33
ACMSD Q8TDX5 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
ADORA2A P29274 1/20 0.33
SOS2 Q07890 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL5956032 0.85 PABPC1 (0.53) PABPC1ALDH1A1KDM4EKMT2AMEN1
Iodide SCHEMBL3396751 0.78 ALDH1A1 (0.49) PABPC1ALDH1A1KDM4EKMT2AMEN1
SCHEMBL12257970 0.76 ALDH1A1 (0.50) PABPC1ALDH1A1KDM4EKMT2AMEN1
SCHEMBL9323548 0.75 AHR (0.46) AHRKDM4ECES1RAB9ADAGLA
SCHEMBL28719014 0.75 GSK3B (0.46) AHRKDM4ECES1DAGLAALOX15
Bromide SCHEMBL7770315 0.75 ALDH1A1 (0.49) PABPC1ALDH1A1KDM4EKMT2AMEN1
SCHEMBL1244495 0.74 KDM4E (0.61) AHRKDM4ECES1KMT2AALOX15
SCHEMBL17064418 0.71 AHR (0.40) AHRCES1DAGLA
SCHEMBL31067700 0.71 AHR (0.40) AHRCES1DAGLA
Pyridine SCHEMBL8597415 0.71 AHR (0.40) AHRALDH1A1KDM4ECES1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248870-B1 OLIGO-2,6-PYRIMIDINE COMPLEXING AGENT. NYCOMED IMAGING AS (NO) 2001-06-19 US disclosed
US-5817774-A Unsymmetrical complexing agents and targeting immunoreagents useful in therapeutic and diagnostic compositions and methods STERLING WINTHROP INCORPORATION (US) 1998-10-06 US disclosed
US-5760191-A Macrocyclic complexing agents and targeting immunoreagents useful in therapeutic and diagnostic compositions and methods NYCOMED IMAGING AS (NO) 1998-06-02 US disclosed
US-5559214-A Unsymmetrical complexing agents and targeting immunoreagents useful in thearpeutic and diagnostic compositions and methods STERLING WINTHROP INC. (US) 1996-09-24 US disclosed
US-5539117-A 2-acetyl-6-cyanopyridines and their use as intermediates in the synthesis of oligo-2,6-pyridines GE HEALTHCARE AS (NO) 1996-07-23 US disclosed
US-5350696-A 2-acetyl-6-cyanopyridines and their use as intermediates in the synthesis of oligo-2,6-pyridines STERLING WINTHROP, INC. (US) 1994-09-27 US disclosed